← Back to Clinical Trials
Recruiting NCT07486661

NCT07486661 A Pilot Project for PLWH Aged 65-75: Preventing the Development of Frailty

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07486661
Status Recruiting
Phase —
Sponsor Centre Hospitalier Universitaire Saint Pierre
Condition Age Group: 65-74
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-08-28
Primary Completion 2028-07

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 74 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-08-28 with a primary completion date of 2028-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In ageing populations, the main risk is the development of a syndrome of frailty, characterized by the addition of polymorbidity, polymedication, psychosocial difficulties, cognitive disorders, ... This functional decline is linked to a reduction in the person's functional reserves, and will lead to an increase in health problems, hospitalizations and, ultimately, mortality. People living with HIV (PLWH) over 50 develop the same kind of comorbidities as HIV-uninfected people over 75 years-old. In Belgium, the care of PLWH\< 75 years with frailty syndrome is not reimbursed by healthcare insurance, and geriatric assessment and management is therefore not possible in this age group, despite the very real need. Goals of this project are: 1. Determine the proportion and characterize the population of PLWH aged 65 and over who screen positive using the Fried scale 2. Validate the application of the Fried scale in a population of PLWH 3. Offer a care pathway model to prevent the onset of frailty in people screened as at-risk and who do not benefit from routine screening or care pathway reimbursement. Projets proposal: * Systematic screening of all PLWH aged 65-74 at the MIA Center, by the nurse prior to physician consultation, using the Fried scale. * Send all PLWH aged 65-74 who screen positive to Geriatric One Day for an ergo-geriatric consultation to confirm the risk of frailty and set up a preventive care pathway * After treatment, perform a patient satisfaction questionnaire + a new Fried scale at one year

Eligibility Criteria

Inclusion Criteria: * living with HIV * between 65-74 years Exclusion Criteria: * none

Contact & Investigator

Central Contact

Agnes LIBOIS, MD

✉ maladiesinfectieuses@stpierre-bru.be

📞 +3225354130

Frequently Asked Questions

Who can join the NCT07486661 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 74 Years, studying Age Group: 65-74. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07486661 currently recruiting?

Yes, NCT07486661 is actively recruiting participants. Contact the research team at maladiesinfectieuses@stpierre-bru.be for enrollment information.

Where is the NCT07486661 trial being conducted?

This trial is being conducted at Brussels, Belgium.

Who is sponsoring the NCT07486661 clinical trial?

NCT07486661 is sponsored by Centre Hospitalier Universitaire Saint Pierre. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology